Long Term Follow up of Patients Who Were Treated With Extracorporeal Membrane Oxygenation for Pandemic Influenza A/H1N1 Induced Severe Respiratory Failure
Sponsor
Karolinska University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01763060
Collaborator
Karolinska Institutet (Other), Uppsala University Hospital (Other)
7
1
12
0.6
Study Details
Study Description
Brief Summary
Patients treated with Extracorporeal Membrane Oxygenation (ecmo) for severe respiratory or circulatory failure show severe long term disability due to impaired lung -, cerebral-, cognitive function and impaired quality of life. This study investigates the long term outcome of all patients who are still alive three years after ECMO treatment for severe respiratory failure during the H1N1 2009 pandemic at the Karolinska University Hospital.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
7 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Study Start Date
:
Oct 1, 2012
Actual Primary Completion Date
:
Oct 1, 2013
Actual Study Completion Date
:
Oct 1, 2013
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| ECMO survivors CT scan of the chest of all ECMO survivors after 2009/2010 pandemics Tests for cognitive function MRI of the brain Lung function |
Radiation: CT scan
Behavioral: Cognitive function
Radiation: MRI
|
Outcome Measures
Primary Outcome Measures
- Lung function [3 years after ecmo treatment]
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 60 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- Survivors of ECMO treatment for influenza a/h1n1 pneumonia during 2009/2010 pandemics at the ECMO Center Karolinska
Exclusion Criteria:
- None
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Karolinska University Hospital | Stockholm | Sweden | 17176 |
Sponsors and Collaborators
- Karolinska University Hospital
- Karolinska Institutet
- Uppsala University Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Bernhard Holzgraefe,
MD,
Karolinska University Hospital
ClinicalTrials.gov Identifier:
NCT01763060
Other Study ID Numbers:
- Dnr 2012/986-31/3
- Long term outcome
First Posted:
Jan 8, 2013
Last Update Posted:
Nov 21, 2013
Last Verified:
Nov 1, 2013